Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Nanotechnology, Nanoparticle Drug Delivery

Omid Farokhzad

MD

🏢Harvard Medical School / Brigham and Women's Hospital🌐USA

Professor, Department of Anesthesiology

89
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Omid Farokhzad is a pioneer in targeted polymeric nanoparticle platforms for cancer drug delivery. He developed BIND-014, a docetaxel-loaded PLGA-PEG nanoparticle bearing PSMA-targeting aptamers, demonstrating feasibility of actively targeted nanoparticles in phase I trials. His research has explored the EPR effect, active targeting strategies, and controlled release mechanisms in cancer nanomedicine, and he has translated multiple nanoparticle platforms toward clinical investigation.

Share:

🧪Research Fields 研究领域

nanoparticle cancer drug delivery
PLGA nanoparticles
targeted nanoparticle aptamer
prostate cancer nanoformulation
docetaxel nanoparticle BIND-014

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Omid Farokhzad 的研究动态

Follow Omid Farokhzad's research updates

留下邮箱,当我们发布与 Omid Farokhzad(Harvard Medical School / Brigham and Women's Hospital)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment